Form 8-K - Current report:
SEC Accession No. 0001193125-24-222116
Filing Date
2024-09-19
Accepted
2024-09-19 16:13:59
Documents
14
Period of Report
2024-09-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d880684d8k.htm   iXBRL 8-K 25420
2 EX-10.1 d880684dex101.htm EX-10.1 25392
  Complete submission text file 0001193125-24-222116.txt   181946

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aadi-20240915.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20240915_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20240915_pre.xml EX-101.PRE 11255
16 EXTRACTED XBRL INSTANCE DOCUMENT d880684d8k_htm.xml XML 3650
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 241310561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)